THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer
Citations Over TimeTop 11% of 2016 papers
Abstract
Colorectal cancer is one of the most common leading causes of death worldwide. Prognostic at an early stage is a useful way that decrease and avoid mortality. Although remarkable progress has been made to investigate the underlying mechanism, the understanding of the complicated carcinogenesis process was enormously hindered by large-scale tumor heterogeneity. Here we proposed that the prognosis-related gene THBS2, responsible for cooperativity disorientation, probably contain untapped prognostic resource of colorectal cancer. We originally established Spearman correlation transition, Kaplan-Meier survival analysis and meta-analysis that combine public dataset and clinical samples to quantify the prognostic value of THBS2. THBS2 could be considered as a novel prognostic marker in colorectal cancer.
Related Papers
- → Supporting evidence for using biomarkers in the diagnosis of MCI due to AD(2012)55 cited
- → Tumorigenesis and cell evolution(1995)
- Expression of PTTG and its significance in colorectal cancer(2008)
- → P4‐123: Resolving Conflicting CSF Biomarker Information in Alzheimer′s Disease(2016)
- → Progress of the relationship between aberrant p53 protein and tumorigenesis(2019)